by pulsepartner | Oct 14, 2026 | Blog Post
Policymakers are increasingly focused on strengthening domestic life sciences manufacturing. A healthy, predictable environment for life sciences mergers and acquisitions (M&A) should be part of that effort. Building a life sciences manufacturing footprint is no...
by pulsepartner | Sep 30, 2026 | Blog Post
PULSE continues to spotlight the unique and fundamental role of mergers and acquisitions (M&A) and other collaborations in supporting America’s innovative life sciences ecosystem. Read below for recent PULSE updates and commentaries. Innovations Advanced by...
by pulsepartner | Sep 9, 2026 | Blog Post
A recent Financial Times article, authored by Hugh Rienhoff, highlights a rising challenge for America’s life sciences ecosystem: as biotechnology fundraising has declined, venture capital (VC) investors are increasingly prioritizing later-stage drug candidates that...
by pulsepartner | Aug 26, 2026 | Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this series here....
by pulsepartner | Aug 12, 2026 | Blog Post
A new BioSpace article highlights an urgent challenge: maintaining America’s leadership in developing rare disease treatments amid increasing global competition. Meeting that challenge will require policies that support the full life sciences innovation ecosystem –...
by pulsepartner | Jul 29, 2026 | Innovations Advanced by M&A
This blog is the latest installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this series...
